Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics.
Observe Medical is listed on Euronext Oslo under OBSRV.
Link to Notice of EGM 7.1.2025 here and link for registration can be found here
Issuer name: Observe Medical ASA Ex. date: 14 January 2025 Type of corporate action: Reverse share split Other information: Fifteen (15) old shares will give one (1) new share. After the reverse share split, the share capital is NOK 75,107,806.80 divided into 19,258,412 shares, each with a nominal value of NOK 3.90. The shares in…
Read moreDate on which the corporate action was made public: 17 December 2024. Reverse split ratio: 15 old shares give 1 new share. Last day including right: 13 January 2025. Ex-date: 14 January 2025. Record date: 15 January 2025. Date of approval: 7 January 2025. Other information (optional): A new ISIN number will be issued for…
Read moreIssuer: Observe Medical ASA Previous ISIN: NO0010865009 New ISIN: NO0013457952 Date of ISIN change: 14 January 2025 This information is published in accordance with the requirements of the Continuing Obligations for companies listed on the Oslo Stock Exchange and Euronext Expand. For further information, please contact: Jørgen Mann, CEO Observe Medical Mobile: +45 408 67…
Read moreFollow the development of the Observe Medical share at Oslo Stock Exchange under the OBSRV ticker. Observe Medical ASA has been listed on the Oslo Stock Exchange since November 4, 2019.
To view all stock exchange releases form the Company, please review Oslo Stock Exchange NewsWeb under the OBSRV ticker.
As at 31 December 2024
| Name | Number of shares | % of top 20 | % of total | Country | ||
|---|---|---|---|---|---|---|
| 1 | NAVAMEDIC ASA | 45,109,765 | 21.85% | 15.62% | Norway | |
| 2 | INGERØ REITEN INVESTMENT COMPANY AS | 31,553,565 | 15.28% | 10.92% | Norway | |
| 3 | JPB AS | 17,564,944 | 8.51% | 6.08% | Norway | |
| 4 | ELI AS | 13,263,298 | 6.42% | 4.59% | Norway | |
| 5 | SKØYEN INVEST AS | 10,074,159 | 4.88% | 3.49% | Norway | |
| 6 | GINNY INVEST AS | 9,250,000 | 4.48% | 3.20% | Norway | |
| 7 | F2 FUNDS AS | 9,000,000 | 4.36% | 3.12% | NORWAY | |
| 8 | SILVERCOIN INDUSTRIES AS | 8,296,150 | 4.02% | 2.87% | Norway | |
| 9 | ALPINE CAPITAL AS | 7,482,036 | 3.62% | 2.59% | Norway | |
| 10 | BJØRNTVEDT, VEGARD | 7,165,922 | 3.47% | 2.48% | Norway | |
| 11 | CAM AS | 6,633,162 | 3.21% | 2.30% | Norway | |
| 12 | RO, LARS | 6,266,626 | 3.04% | 2.17% | NORWAY | |
| 13 | PHILIP HOLDING AS | 5,500,000 | 2.66% | 1.90% | Norway | |
| 14 | KING KONG INVEST AS | 5,000,000 | 2.42% | 1.73% | Norway | |
| 15 | QUICK ISLAND INVEST AS | 4,715,337 | 2.28% | 1.63% | Norway | |
| 16 | JOHANSSON, ERIC | 4,250,000 | 2.06% | 1.47% | Norway | |
| 17 | WANGESTAD, ANDREAS | 4,105,000 | 1.99% | 1.42% | Norway | |
| 18 | LIVERMORE INVEST AS | 4,038,254 | 1.96% | 1.40% | Norway | |
| 19 | GUNERIUS PETTERSEN AS | 3,725,000 | 1.80% | 1.29% | Norway | |
| 20 | LAPAS AS | 3,468,311 | 1.68% | 1.20% | Norway | |
| Total number owned by top 20 | 206,461,529 | 100.00% | 71.47% | |||
| Total number of shares | 288,876,175 | |||||
| Total number of shareholders | 2,148 |
Stock Exchange:
Ticker:
First day of listing:
Sector:
Trading Currency:
ISIN:
Number of shares issued:
Nominal value:
Euronext Expand Oslo
OBSRV
4 November 2019
Healthcare
NOK
NO0010865009
288 876 175
NOK 0.26
The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bård Brath Ingerø (chair) and Grete Hogstad.
The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.
For nomination committee please contact:
Bård Brath Ingerø, Chair of the Nomination Committee
+47 92 83 33 34 / bbi@reitenco.no
7 January 2025: Observe Medical ASA – Notice of Extraordinary General Meeting in connection with reverse share split
Link for Electronic registration
17 July 2024: Observe Medical ASA – Minutes from Extraordinary General Meeting
26 June 2024: Observe Medical ASA – Notice of Extraordinary General Meeting
24 May 2024: Observe Medical ASA – Minutes from Annual General Meeting
3 May 2024: Notice of Annual General Meeting on 24 May 2024, including attendance, advance vote, and proxy forms
3 May 2024: Nomination Committee recommendation
3 May 2024: Observe Medical – Report of salary and other remuneration to leading personnel
22 November 2023: Observe Medical ASA – Minutes Extraordinary General Meeting
1 November 2023: Attendance and proxy form to the extraordinary general meeting
Shareholders who receive the notice electronically must log in to investor services (click on events, general meeting) for their registration
1 November 2023: Observe Medical ASA – Notice of Extraordinary General Meeting 22 November 2023
26 May 2023: Observe Medical ASA – Minutes from Annual General Meeting
26 May 2023: Represented List
5 May 2023:Notice of Annual General Meeting on 26 May 2023
5 May 2023: Notice of attendance and proxy form to the AGM on 26 May 2023
5 May 2023: VPS – Investor services
5 May 2023: Nomination Committee recommendation
5 May 2023: Observe Medical – Report of salary and other remuneration to leading personnel
3 June 2022: Minutes from Annual General Meeting 2022
3 June 2022: Represented list
31 May 2022: Board of Directors recommendation for appointment of auditor
31 May 2022: The Nomination Committee recommendation part 2
13 May 2022: Notice of Annual General Meeting on 3 June 2022
13 May 2022: Notice of attendance and proxy form to the Annual General Meeting on 3 June 2022
13 May 2022: The Nomination Committee’s recommendation (part 1)
13 May 2022: Guidelines for determination of salary and other remuneration to executive personnel
13 May 2022: Report on salary and other remuneration to executive personnel year 2021
13 May 2022: VPS – Investor services
13 May 2022: LUMI
13 May 2022: Online guide LUMI (Norsk)
13 May 2022: Online guide LUMI (English)
4 February 2022: Minutes from Extraordinary General Meeting
4 February 2022: Represented list
14 January 2022: Notice of Extraordinary General Meeting on 4 February 2022
14 January 2022: Notice of attendance and proxy form to the Extraordinary General Meeting on 4 February 2022
21 May 2021: Minutes from Annual General meeting
30 April 2021: Notice of Annual General Meeting on 21 May 2021
30 April 2021: Notice of attendance and proxy form to the Annual General meeting on 21 May 2021
30 April 2021: The Nomination Committee’s recommendation
30 April 2021: Guidelines for determination of salary and other remuneration to executive Personnel
30 June 2020: Annual General Meeting
16 June 2020: Extraordinary General Meeting
9 June 2020: Notice of Annual General Meeting on 30 June 2020
9 June 2020: Attendance to the Annual General Meeting on 30 June 2020
9 June 2020: Recommendation by the Nomination Committee
9 June 2020: The Boards declaration on remuneration to executive management
26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020
26 May 2020: Attendance to the Extraordinary General Meeting on 16 June 2020
24 October 2019: Extraordinary General Meeting
1 October 2019: Extraordinary General Meeting
5 August 2019: Extraordinary General Meeting
Jørgen Mann, Chief Executive Officer
+45 40 86 75 58 / jørgen.mann@observemedical.com
Johan M. Fagerli, Chief Financial Officer
+47 95 81 27 65 / johan.fagerli@observemedical.com